Angiotensin Ii Acetate Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 2 pharmaceutical companies such as LA JOLLA PHARMA, GLAND. It is marketed under 2 brand names, including GIAPREZA, ANGIOTENSIN ll ACETATE. Available in 3 different strengths, such as EQ 2.5MG BASE/ML (EQ 2.5MG BASE/ML), EQ 5MG BASE/2ML (EQ 2.5MG BASE/ML), EQ 0.5MG BASE/ML (EQ 0.5MG BASE/ML), and administered through 1 route including SOLUTION;INTRAVENOUS.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 2 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...
watch_later Watch: autorenew Loading watch analysis...
rocket_launch Opportunity: autorenew Loading opportunity analysis...
flag
gavel
calendar_today
calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
✓ Latest exclusivity data and extensions
Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength Route of Administration Companies Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

Patent Number Publication Date Legal Status Patent Expiry Date
{"application_id":"73795","ingredient":"ANGIOTENSIN II ACETATE","trade_name":"GIAPREZA","family_id":"e79e0d41f3b34bbfbafd","publication_number":"US10335451B2","cleaned_patent_number":"10335451","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-12-16","publication_date":"2019-07-02","legal_status":"Granted"} US10335451B2 02 Jul, 2019 Granted 16 Dec, 2029
{"application_id":"73792","ingredient":"ANGIOTENSIN II ACETATE","trade_name":"GIAPREZA","family_id":"e79e0d41f3b34bbfbafd","publication_number":"US9867863B2","cleaned_patent_number":"9867863","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-12-16","publication_date":"2018-01-16","legal_status":"Granted"} US9867863B2 16 Jan, 2018 Granted 16 Dec, 2029
{"application_id":"73796","ingredient":"ANGIOTENSIN II ACETATE","trade_name":"GIAPREZA","family_id":"e79e0d41f3b34bbfbafd","publication_number":"US10500247B2","cleaned_patent_number":"10500247","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-12-16","publication_date":"2019-12-10","legal_status":"Granted"} US10500247B2 10 Dec, 2019 Granted 16 Dec, 2029
{"application_id":"73797","ingredient":"ANGIOTENSIN II ACETATE","trade_name":"GIAPREZA","family_id":"e79e0d41f3b34bbfbafd","publication_number":"US10548943B2","cleaned_patent_number":"10548943","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-12-16","publication_date":"2020-02-04","legal_status":"Granted"} US10548943B2 04 Feb, 2020 Granted 16 Dec, 2029
{"application_id":"73793","ingredient":"ANGIOTENSIN II ACETATE","trade_name":"GIAPREZA","family_id":"e79e0d41f3b34bbfbafd","publication_number":"US9572856B2","cleaned_patent_number":"9572856","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-07-18","publication_date":"2017-02-21","legal_status":"Granted"} US9572856B2 21 Feb, 2017 Granted 18 Jul, 2031
{"application_id":"73787","ingredient":"ANGIOTENSIN II ACETATE","trade_name":"GIAPREZA","family_id":"fd7577459ee84d85af49","publication_number":"US11096983B2","cleaned_patent_number":"11096983","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-12-18","publication_date":"2021-08-24","legal_status":"Granted"} US11096983B2 24 Aug, 2021 Granted 18 Dec, 2034
{"application_id":"73785","ingredient":"ANGIOTENSIN II ACETATE","trade_name":"GIAPREZA","family_id":"fd7577459ee84d85af49","publication_number":"US10493124B2","cleaned_patent_number":"10493124","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-12-18","publication_date":"2019-12-03","legal_status":"Granted"} US10493124B2 03 Dec, 2019 Granted 18 Dec, 2034
{"application_id":"73784","ingredient":"ANGIOTENSIN II ACETATE","trade_name":"GIAPREZA","family_id":"fd7577459ee84d85af49","publication_number":"US10028995B2","cleaned_patent_number":"10028995","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-12-18","publication_date":"2018-07-24","legal_status":"Granted"} US10028995B2 24 Jul, 2018 Granted 18 Dec, 2034
{"application_id":"73788","ingredient":"ANGIOTENSIN II ACETATE","trade_name":"GIAPREZA","family_id":"fd7577459ee84d85af49","publication_number":"US11559559B2","cleaned_patent_number":"11559559","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-12-18","publication_date":"2023-01-24","legal_status":"Granted"} US11559559B2 24 Jan, 2023 Granted 18 Dec, 2034
{"application_id":"73757","ingredient":"ANGIOTENSIN II ACETATE","trade_name":"GIAPREZA","family_id":"fd7577459ee84d85af49","publication_number":"US9220745B2","cleaned_patent_number":"9220745","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-12-18","publication_date":"2015-12-29","legal_status":"Granted"} US9220745B2 29 Dec, 2015 Granted 18 Dec, 2034
{"application_id":"73799","ingredient":"ANGIOTENSIN II ACETATE","trade_name":"GIAPREZA","family_id":"2f717e46301b442b8b32","publication_number":"US11219662B2","cleaned_patent_number":"11219662","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-01-06","publication_date":"2022-01-11","legal_status":"Granted"} US11219662B2 11 Jan, 2022 Granted 06 Jan, 2037

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID Title Status Phase Conditions Start Date Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

View Complete Supplier List

Unlock access to all suppliers of Angiotensin Ii Acetate

✓ Access a comprehensive list of global suppliers
✓ Get information on each supplier
Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.

GreyB © 2025 Elixir. All rights reserved.